Product Description
SFI Health Ther-Biotic Target B2 supports breast health during lactation while promoting infant immune health. This formula offers a safe and effective way to prevent, reduce, and resolve lactation discomfort and dysbiosis. Breast milk not only provides essential nutrients for infant growth but also plays a crucial role in shaping the infant microbiome, influencing long-term health. Research suggests that probiotics taken orally by mothers can directly impact breast microbiota through enteric-breast circulation, which is heightened during late pregnancy and lactation.
Conventional treatments for lactation discomfort often come with drawbacks, including side effects, maternal dysbiosis, and potential disruption of infant immune development. With growing evidence supporting the benefits of probiotics in human milk, Ther-Biotic Target B2 provides a science-backed, natural approach to maternal breast and infant immune health. This makes it a valuable option for obstetricians, lactation consultants, midwives, and other healthcare professionals dedicated to supporting breastfeeding mothers.
